Shukra Pharmaceuticals Ltd (NSE: SHUKRAPHAR), ISIN INE551C01044 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SHUKRAPHAR last traded at ₹30.10 (-2.81%), with a 52-week range of ₹17.06 to ₹65.26 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 50.96%, FIIs 0.00%, DIIs 0.11%, mutual funds 0.00%.
EquiSense Score (ECS): 14/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.